Valuation: Sysmex Corporation

Market Cap 994B 6.27B 5.44B 5.09B 4.66B 8.78B 596B 8.92B 59.17B 23.37B 299B 23.55B 23.04B P/E 2027 *
25x
P/E 2028 * 20.4x
Enterprise Value 1,013B 6.39B 5.54B 5.19B 4.75B 8.95B 608B 9.09B 60.28B 23.81B 305B 23.99B 23.47B EV / Sales 2027 *
1.89x
EV / Sales 2028 * 1.79x
Free-Float
72.3%
Yield 2027 *
2.36%
Yield 2028 * 2.46%
1 day+0.89%
1 week-1.88%
Current month+2.63%
1 month+7.36%
3 months+23.24%
6 months+9.99%
Current year+6.39%
1 week 1,553
Extreme 1553
1,641
1 month 1,494
Extreme 1494
1,689
Current year 1,246
Extreme 1246
1,689
1 year 1,246
Extreme 1246
2,114
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%-1.88%-33.68%-46.31% 6.25B
+2.13%-0.04%-17.39%+0.29% 183B
-0.08%-1.85%-4.18%+2.24% 110B
+2.46%+2.01%+11.17%+75.37% 61.72B
-1.64%+7.20%+39.25%+56.58% 54.98B
+3.76%+5.15%+0.10%-34.61% 47.02B
-5.88%-13.90% - - 32.16B
+0.44%+10.49%+10.02%-31.01% 31.19B
-0.69%+3.30%+45.94%-7.06% 24.7B
-0.40%-1.30%+3.53%+2.55% 22.68B
Average +0.10%+0.98%+6.08%+2.00% 57.37B
Weighted average by Cap. +0.74%+0.16%+0.97%+9.34%

Financials

2027 *2028 *
Net sales 536B 3.38B 2.94B 2.75B 2.52B 4.74B 322B 4.81B 31.94B 12.61B 161B 12.71B 12.43B 566B 3.57B 3.1B 2.9B 2.65B 5B 340B 5.08B 33.69B 13.31B 170B 13.41B 13.12B
Net income 40.28B 254M 221M 206M 189M 356M 24.17B 362M 2.4B 947M 12.12B 954M 934M 49.11B 310M 269M 252M 230M 434M 29.47B 441M 2.92B 1.15B 14.78B 1.16B 1.14B
Net Debt 18.61B 117M 102M 95.32M 87.3M 164M 11.17B 167M 1.11B 438M 5.6B 441M 431M 18.81B 119M 103M 96.37M 88.26M 166M 11.29B 169M 1.12B 442M 5.66B 446M 436M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
06/08/26 JP¥1,641.00 +0.89% 1,809,300
05/08/26 JP¥1,626.50 +0.99% 2,640,500
04/08/26 JP¥1,610.50 +0.91% 2,058,900
03/08/26 JP¥1,596.00 -0.19% 2,866,700
31/07/26 JP¥1,599.00 -4.25% 2,330,300
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,641.00JPY
Average target price
1,774.29JPY
Spread / Average Target
+8.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock